Abstract
Object. Somatostatin receptors have been found on a variety of tumours like neuroendocrine breast or brain tumours. Their detection opens new diagnostic and therapeutic paths. The aim of this work was to investigate their expression in medulloblastomas.
Methods. Using both techniques, reverse transcriptase-polymerase chain reaction and immunohistochemistry, we analysed mRNA of different subtypes of somatostatin receptors in 15 medulloblastomas and the localisation of the subtype SSTR2 receptor at the cellular level in 13 medulloblastomas. All five subtypes mRNA were variably expressed in each medulloblastoma. The signal obtained after Southern blotting for SSTR2 receptor amplification was the highest as compared to the signal obtained for the other receptor subtypes. Immunostaining for SSTR2A receptor was present in every tumour specimen and was specifically located to the cellular membrane of neoplastic cells. No staining was identified at the level of peritumoral veins.
Conclusion. The evidence of predominant expression of SSTR2 receptors in medulloblastomas opens interesting prospects for their diagnosis and therapy.
Similar content being viewed by others
References
Patel YC: Somatostatin and its receptor family. Frontiers Neuroendo 20: 157–198, 1999
Pollak MN, Schally AV: Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med 217: 143–152, 1998
Reisine T, BELL GI: Molecular biology of somatostatin receptors. Endocr Rev 16: 427–442, 1995
Schindler M, Holloway S, Humphrey PPA, Waldvogel H, Faull RLM, Berger W, Emson PC: Localization of the somatostatin SST2A receptor in human cerebral cortex, hippocampus and cerebellum. Neuro Report 9: 521–525, 1998
Thoss VS, Perez J, Probat A, Hoyer D: Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Arch Pharmacol 354: 411–419, 1996
Reubi JC, Maurer R, Von Werder K, Torhorst J, Klijn JGM, Lamberts SWJ: Somatostatin receptors in human endocrine tumors. Cancer Res 47: 551–558, 1987
Schaer JC, Waser B, Mengod G, Reubi JC: Somatostatin receptor subtypes SST1, SST2, SST3 and SST5 expression in human pituitary, gastroenteropancreatic and mammary tumors. Comparison of mRNA analysis with receptor autoradiography. Int J Cancer 70: 530–537, 1997
Vikic-Topic S, Reisch KP, Kvols LK, Vuk-Pavlovic S: Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab 80: 2974, 1995
Reubi JC, Waser B, Schaer JC, Marwalder R: Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab 80: 2806–2814, 1995
Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N, Susini C: Loss of SST2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 56: 1823–1827, 1996
Dutour A, Kumar U, Panetta R, Ouafik L, Fina F, Sasi R, Patel YC: Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer 76: 620–627, 1998
Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SWJ: Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 47: 5758–5764, 1987
Reubi JC, Schaer JC, Waser B, Mengod G: Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54: 3455–3459, 1994
Feindt J, Becker I, Blomer U, Hugo HH, Mehdorn HM, Krisch B, Mentlein R: Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J Neurochem 65: 1997–2005, 1995
Lamszus K, Meyerhof W, Westphal M: Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas. J Neuro-Oncol 35: 353–364, 1997
Fruhwald MC, O'Dorisio MS, Pietsch T, Reubi JC: High expression of somatostatin receptor subtype 2 (SST2) in medulloblastoma: implications for diagnosis and therapy. Pediat Res 45: 697–708, 1999
Muller HL, Fruhwald MC, Scheubeck M, Rendl J, Warmuth-Metz M, Sorensen N, Kuhl J, Reubi JC: A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma. J Neuro-Oncol 38: 27–40, 1998
Chomczynsky P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Sein S: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 89: 251–255, 1992
Corness JD, Demchyshyn LL, Seeman P, Van Tol HHM, Srikant CB, Kent G, Patel YC, Niznik HB: Ahuman somatostatin receptor (SSTR3), located on chromosome 22, dysplays preferential affinity for somatostatin-14 like peptides. Febs Lett 321: 279–284, 1993
Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S, Seino Y: Cloning, functional expression and pharmacological characterization of a fourth (h SSTR5) and a fifth (h SSTR4) human somatostatin receptor subtype. Bioch Bioph Res Com 195: 844–852, 1993
Schulz S, Schmitt J, Wiborny D, Schmidt H, Olbricht S, Weise W, Roessner A, Gramsch C, Hollt V: Immunocytochemical detection of somatostatin receptors SST1, SST2A, SST2B and SST3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Canc Res 4: 2047–2052, 1998
Patel YC, Greenwood MT, Panetta R, Hukovic N, Grigorakis S, Robertson LA, Srikant CB: Molecular biology of somatostatin receptor sub-types. Metabolism 45: 31, 1996
Vanetti M, Vogt G, Hollt V: The two isoforms of the moure SRIF receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to anedylate cyclase and in agonist-induced receptor desnsitization. Febs Lett 331: 260–266, 1993
Helboe L, Moller M, Novregaard L, Schiodt M, Stidensen DE: Developement of selective antibodies against the human somatostatin receptor subtypes SST1–SST5. Mol Brain Res 49: 82–88, 1997
Reubi JC, Kappeler A, Waser B, Schondrunn A, Laissue J: Immunohistochemical localization of somatostatin receptor SST2A in human pancreatic islets. J Clin Endo Meta 83: 3746–3749, 1998
Reubi JC, Kappeler A, Waser B, Laissue J, Hipkin RW, Schonbrunn A: Immunohistochemical localization of somatostatin receptors SST2A in human tumors. Am J Path 153: 233–245, 1998
Denzler B, Reubi JC: Expression of somatostatin receptors in peritumoral veins of human tumors. Cancer 85: 188–198, 1999
Rorke LB, Trojanowski JQ, Lee VMY, Zimmerman RA, Sutton LN, Biegel JA, Goldwein JW, Packer RJ: Primitive neuroectodermal tumors of the central nervous system. Brain Path 7: 765–784, 1997
Viollet C, Bodenant C, Prunotto C, Roosterman D, Schaefer J, Meyerhof W, Epelbaum J, Vaudry H, Leroux P: Differential expression of multiple somatostatin receptors in the rat cerebellum during development. J Neurochem 68: 2263–2272, 1997
Qualman SI, O'Donsio MS, Fleshman DJ, Labanowski J, Shimada H, O'Dorisio TM: Neuroblastoma: correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 70: 2005–2012, 1992
Giordana MT, Schiffer P, Schiffer D: Prognostic factors in medulloblastoma. Child's Nerv Syst 14: 256–262, 1998
Steinbok P, Hentschel S, Cochrane DD, Kestle JR: Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 84: 726–732, 1996
Limouris GS, Rassidakis A, Kondi-Paphiti A, Triantafyllou N, Manetou A, Giannakopoulos V, Toubanakis N, Psyhojios I, Stavraka A, Vlahos L: Somatostatin receptor scintigraphy of non-neuroendocrine malignancies with 111In-Pentetreotide. Anticancer Res 17: 1593–1598, 1997
Schmidt M, Scheidhauer K, Luyken C, Voth E, Hildebrandt G, Klug N, Schicha H: Somatostatin receptor imaging in intracranial tumours. Eur J Nuc Med 25: 675–686, 1998
Feindt J, Mentlein R, Krisch B: Time-dependent influence of the somatostatin analogue octreotide on the proliferation of rat astrocytes and glioma cells. Brain Res 746: 309–313, 1997
Lamberts SW, Van Der Lely A, Deherder WW, Hofland LJ: Drug therapy: octreotide. New Eng J Med 334: 246–254, 1996
Kahan Z, Nagy A, Schally AV, Hebert F, Sun B, Groot K, Halmos G: Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of targeted cytotoxic analog of somatostatin, AN-238. Int J Cancer 82: 592–598, 1999
Merlo A, Hausmann O, Wasner M, Steiner P, Otte A, Jermann E, Freitag P, Reubi JC, Muller-Brand J, Gratzl O, Macke HR: Locoregional regulatory peptide receptor targeting with the diffusible somatostatine analogue 90-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas. Clin Canc Res 5: 1025–1033, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guyotat, J., Champier, J., Saint Pierre, G. et al. Differential Expression of Somatostatin Receptors in Medulloblastoma. J Neurooncol 51, 93–103 (2001). https://doi.org/10.1023/A:1010624702443
Issue Date:
DOI: https://doi.org/10.1023/A:1010624702443